Literature DB >> 3902987

Effects of antifungal agents on ergosterol biosynthesis in Candida albicans and Trichophyton mentagrophytes: differential inhibitory sites of naphthiomate and miconazole.

T Morita, Y Nozawa.   

Abstract

The effects of naphthiomate and miconazole showing ergosterol biosynthesis inhibition on Candida albicans and Trichophyton mentagrophytes were investigated by measuring [14C]acetate incorporation into sterols and its precursors. Naphthiomate, like allylamine compounds, was found to interfere with fungal ergosterol biosynthesis by preventing the conversion of squalene into squalene epoxide which is mediated by squalene epoxidase. This metabolic inhibition resulted in a considerable decrease of ergosterol with a corresponding increase of squalene, which is more distinct in T. mentagrophytes than in C. albicans. This indicates that naphthiomate blocks the utilization of squalene by inhibition of squalene epoxidation; unlike N-substituted imidazole, miconazole has been known to inhibit ergosterol formation by inhibiting C14-demethylation. In addition, it is of interest to note that miconazole causes a great accumulation of lanosterol in C. albicans cells, while in T. mentagrophytes cells there was instead a drastic increase of 24-methylenedihydrolanosterol but not lanosterol. The results obtained from this study indicate that repression of ergosterol synthesis by naphthiomate and miconazole is due to inhibition of squalene epoxidation for the former and C14-demethylation for the latter.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3902987     DOI: 10.1111/1523-1747.ep12277141

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  10 in total

1.  Effects of butenafine hydrochloride, a new benzylamine derivative, on experimental dermatophytosis in guinea pigs.

Authors:  T Arika; M Yokoo; T Hase; T Maeda; K Amemiya; H Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

Review 2.  Overview of medically important antifungal azole derivatives.

Authors:  R A Fromtling
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

3.  Two mechanisms of butenafine action in Candida albicans.

Authors:  W Iwatani; T Arika; H Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

4.  Ergosterol biosynthesis inhibition by the thiocarbamate antifungal agents tolnaftate and tolciclate.

Authors:  N S Ryder; I Frank; M C Dupont
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

5.  Effect of antifungal agents on lipid biosynthesis and membrane integrity in Candida albicans.

Authors:  N H Georgopapadakou; B A Dix; S A Smith; J Freudenberger; P T Funke
Journal:  Antimicrob Agents Chemother       Date:  1987-01       Impact factor: 5.191

6.  Characterization of squalene epoxidase activity from the dermatophyte Trichophyton rubrum and its inhibition by terbinafine and other antimycotic agents.

Authors:  B Favre; N S Ryder
Journal:  Antimicrob Agents Chemother       Date:  1996-02       Impact factor: 5.191

Review 7.  Sterol biosynthesis inhibitors: their current status and modes of action.

Authors:  E I Mercer
Journal:  Lipids       Date:  1991-08       Impact factor: 1.880

8.  Effects of squalene epoxidase inhibitors on Candida albicans.

Authors:  N H Georgopapadakou; A Bertasso
Journal:  Antimicrob Agents Chemother       Date:  1992-08       Impact factor: 5.191

9.  The solid-state conformation of the topical antifungal agent O-naphthalen-2-yl N-methyl-N-(3-methylphenyl)carbamothioate.

Authors:  Douglas M Ho; Michael J Zdilla
Journal:  Acta Crystallogr C Struct Chem       Date:  2018-10-23       Impact factor: 1.172

10.  Host defence peptides identified in human apolipoprotein B as promising antifungal agents.

Authors:  Eliana Dell'Olmo; Rosa Gaglione; Angela Cesaro; Valeria Cafaro; Wieke R Teertstra; Hans de Cock; Eugenio Notomista; Henk P Haagsman; Edwin J A Veldhuizen; Angela Arciello
Journal:  Appl Microbiol Biotechnol       Date:  2021-02-12       Impact factor: 4.813

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.